|
NIAID welcomes our new Council members for 2008: Drs. Ann Arvin, Carol A. Carter, Louis J. Picker, Regina Rabinovich, and Christel H. Uittenbogaart.
Senior Staff
- Chairperson: Anthony S. Fauci, M.D., Director, NIAID, NIH, DHHS
- Executive secretary: Marvin R. Kalt, Ph.D., Director, DEA,
NIAID, NIH, DHHS
- Ex officio members:
- Michael O. Leavitt, Secretary, DHHS
- Elias A. Zerhouni, Jr., M.D., Director, NIH, DHHS
- Other ex officio members are listed beneath their subcommittee.
Acquired Immunodeficiency Syndrome (DAIDS) Subcommittee
| Photo |
Name, Biosketch, and Date Term Ends |
 |
Robert Brooks, M.D., is associate dean for health affairs and professor of family medicine and rural health at the Florida State University College of Medicine. He serves on the Florida Governor's Health Information Technology Advisory Board and the Florida Medicaid Reform Advisory Council. Previously, he was chief of infectious diseases at the Orlando Regional Medical Center. He served in the Florida House of Representatives from 1994 until late 1998 when he was appointed Secretary of the Florida Department of Health. (October 31, 2010) |
 |
Carol A. Carter, Ph.D., is professor of molecular genetics and microbiology and adjunct professor of physiology and biophysics at the State University of New York at Stony Brook. She serves as co-chair of graduate admissions for the Stony Brook Program in Molecular Genetics and Microbiology and director of the summer research internship program for undergraduates. Dr. Carter’s major research interest is replication of HIV with a focus on viral assembly and trafficking events required for virus release from infected cells. She is a member of the NIH Etiology and Pathogenesis Planning Committee. (October 31, 2011) |
 |
Satya Dandekar, Ph.D., is professor and chair, Department of Internal Medicine at the University of California Davis. Her expertise and research interests are in the areas of HIV/AIDS. She has participated in the review of grant applications and program projects for several committees and has been a reviewer for numerous journals and boards. She has lectured on clinical infectious diseases for professional organizations. (October 31, 2010) |
 |
Kathryn M. Edwards, M.D., is professor of pediatrics at Vanderbilt University in Tennessee. She was PI of the NIH-funded placebo-controlled influenza efficacy trial comparing live attenuated and inactivated influenza vaccines in over 3,000 subjects. She is now studying the impact of vaccination programs on disease burden and leads the Vaccine and Treatment Evaluation Unit at Vanderbilt. She served on the CDC's Advisory Committee on Immunization Practices, the FDA's Vaccine and Related Biologic Products Advisory Committee, and the Institute of Medicine Committee for the Evaluation of the Safety and Effectiveness of the Anthrax Vaccine. (October 31, 2009) |
 |
Louis J. Picker, M.D., is associate director of the Vaccine and Gene Therapy Institute and professor of pathology, molecular microbiology, and immunology at Oregon Health and Science University. He is also the director of the Pathobiology and Immunology Division of the Oregon National Primate Research Center. Dr. Picker’s laboratory focuses on delineating the physiology of T cell memory in primates, mechanisms of protection against persistent pathogens, AIDS vaccine development, and the immunopathogenesis of AIDS-causing lentiviruses. (October 31, 2011) |
 |
Christel H. Uittenbogaart, M.D., is professor of pediatrics and microbiology, immunology, and molecular genetics at the University of California, Los Angeles. Her research focuses on the impact of HIV on the developing immune system and the role of immune activation in HIV pathogenesis. She has served on NIH grant review committees. Dr. Uittenbogaart is the executive director of the Midwinter Conference of Immunologists, an annual conference that communicates the most recent developments in the field of immunology. (October 31, 2011) |
| |
Ex officio member:
- Ronald O. Valdiserri, M.D., M.P.H., Chief Consultant, Public Health Strategic Health Care Group, U.S. Department of Veterans Affairs
|
Allergy and Immunology (DAIT) Subcommittee
| Photo |
Name, Biosketch, and Date Term Ends |
 |
Barbara A. Baird, Ph.D., is a professor in the Department of Chemistry and Chemical Biology at Cornell University in New York. She also serves as director of the Nanobiotechnology Center and is PI for Cornell's training grant in molecular biophysics. Dr. Baird's research laboratory uses biochemical and biophysical approaches to investigate basic mechanisms of cell surface receptors in mediating transmembrane signals in immune responses. A primary focus is the high affinity receptor for IgE. She works closely with other interdisciplinary scientists and engineers to develop new technologies and quantitative approaches to cell biology problems. (October 31, 2009) |
|
Richard Insel, M.D., is executive vice president of research of the Juvenile Diabetes Research Foundation International. Dr. Insel leads the strategic direction and oversight for the approximately $100 million in research grants annually awarded to universities and researchers by JDRF -- the world's largest charitable supporter of juvenile diabetes research. He served as a professor of pediatrics and microbiology and immunology at the University of Rochester School of Medicine and Dentistry Medical Center. At Rochester, his research interests were the somatic hypermutation of immunoglobulin genes, generation of memory B-cells, H. influenza vaccines, and developmental immunology. (October 31, 2008) |
 |
Sharon C. Kiely, M.D., M.P.M., is medical director for quality and patient safety at Allegheny General Hospital in Pittsburgh and associate professor of medicine at Drexel University School of Medicine. She has served on the United Network for Organ Sharing board of directors as well as the HHS Secretary’s Advisory Committee on Xenotransplantation. She is a specialist in internal medicine and has focused her clinical, research, and volunteer efforts on juvenile diabetes, medical education, and care to underserved populations, including those with HIV/AIDS. (October 31, 2010) |
 |
Marc E. Rothenberg, M.D., Ph.D., is professor of pediatrics and director of the Division of Allergy and Immunology at Cincinnati Children’s Hospital Medical Center. He also serves as director for the Cincinnati Center for Eosinophilic Disorders. His research focuses on molecular mechanisms of allergic inflammation. He studies the genes and molecules involved in allergic responses, cellular and molecular immunology, and the development and analysis of genetically engineered and antigen-driven models of allergic disease in mice. He also conducts translational clinical trials. (October 31, 2010) |
 |
Megan Sykes, M.D., is Harold and Ellen Danser Professor in the Department of Surgery and professor of medicine at Harvard Medical School. She is an immunologist and associate director of the Transplantation Biology Research Center at Massachusetts General Hospital. Her research is in the areas of hematopoietic cell transplantation, achievement of graft-versus-leukemia effects without graft-versus-host disease, organ allograft tolerance induction, and xenotransplantation. Dr. Sykes is president of the International Xenotransplantation Association and a councilor of the International Transplantation Society. (October 31, 2009) |
 |
David S. Wilkes, M.D., is Dr. Calvin H. English Professor of Medicine, Microbiology, and Immunology at the Indiana University School of Medicine. A pulmonary and critical care physician, he is also the director for the Center for Immunobiology at Indiana. He researches the immunopathogenesis of lung transplant rejection with a focus on alloimmune-induced autoimmunity in lung transplant recipients. Dr. Wilkes has served as a NIH study section member and co-chaired the NIH-sponsored Workshop Summary on Lung Transplantation: Opportunities for Research and Clinical Advancement. (October 31, 2010) |
Microbiology and Infectious Diseases (DMID) Subcommittee
| Photo |
Name, Biosketch, and Date Term Ends |
 |
Ann Arvin, M.D., is Lucile Salter Packard Professor of Pediatrics and professor of microbiology and immunology at Stanford University School of Medicine. She also serves as vice provost and dean of research at Stanford University. Her principal research interests are the human herpesviruses and childhood viral diseases and vaccines. Dr. Arvin conducted early studies of varicella-zoster virus vaccine that is now licensed for the prevention of chickenpox and zoster. She has served on many national committees, including the NIH Collaborative Antiviral Study Group and the National Vaccine Advisory Committee to the secretary, HHS. (October 31, 2011) |
 |
Martin G. Myers, M.D., is professor of pediatrics and preventive medicine and community health at the University of Texas Medical Branch and associate director for public health policy and education at the Sealy Center for Vaccine Development. He serves as president and board chair of a new nonprofit corporation, Immunizations for Public Health, which provides science-based information about vaccines to the public. He is also director and editor of a component organization, the National Network for Immunization Information. Dr. Myers was director of the National Vaccine Program Office in the HHS's Office of Public Health and Science where he coordinated immunization policy with federal organizations and the private sector. (October 31, 2008) |
 |
Shelley M. Payne, Ph.D., is professor of molecular genetics and microbiology, member of the Institute of Cellular and Molecular Biology, and distinguished teaching professor at the University of Texas at Austin. Her research focuses on pathogenic mechanisms of bacterial pathogens, including Shigella, E. coli, and Vibrio cholerae, and the genetics of bacterial iron transport systems. Dr. Payne received a MERIT award for studies on Shigella pathogenesis. She has served as a member and chair of an NIH study section and is on the editorial board of the journal Infection and Immunity. (October 31, 2008) |
 |
Regina Rabinovich, M.D., M.P.H., is director of infectious diseases, Global Health Program at the Bill and Melinda Gates Foundation. She directs the development and implementation of drug and vaccine strategies to prevent, treat, and control diseases relevant to global health, such as malaria, pneumonia, diarrhea, and human papillomavirus (HPV). Dr. Rabinovich is on the board of several organizations involved in global health and infectious diseases, including the National Center for Infectious Diseases at CDC, African Malaria Network Trust, and the Institute for OneWorld Health. (October 31, 2011) |
 |
Martin Rosenberg, Ph.D., is chief scientific officer of Promega Corporation in Madison, Wisconsin. He serves on the Board of Directors for Promega Corporation, Cubist Pharmaceuticals, Medical College of Wisconsin Research Foundation, Nereus Pharmaceuticals, Anacor Pharmaceuticals, and Scarab Genomics. He is also on various academic and industry scientific advisory boards and is editor of Current Opinions in Biotechnology and the Journal of Bacteriology. Dr. Rosenberg is an adjunct professor in the Department of Bacteriology at the University of Wisconsin and the Department of Biochemistry at the Robert Woods Johnson Medical School. (October 31, 2009) |
 |
Gary Schoolnik, M.D., is professor of medicine, microbiology, and immunology at the Stanford Medical School and an attending physician in infectious diseases at Stanford Medical Center. His research uses molecular genetic and genomic methods and combines laboratory and field work in Mexico and Bangladesh to study infectious agents that are significant causes of disease in developing countries. A particular interest is the molecular ecology of infectious agents in natural environmental habitats. Dr. Schoolnik has served as a co-chair of the NIAID Blue Ribbon Panel on Bioterrorism Research and was a founding editor of Molecular Microbiology. (October 31, 2008) |
| |
Ex officio members:
- Mitchell B. Cohen, M.D., Director, Coordinating Center for Infectious Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention
- George W. Weightman, M.D., Major General, U.S. Army Medical Research and Materiel Command (USAMRMC)
|
For more information, see the main Council page. |
Subscribe to Alerts
